Pharmar company information, Employees & Contact Information

Trump Pharma Tariffs Would Raise Drug Prices for Americans Tax Foundation

Why the Pfizer-Trump pharma deal is a win for branded pharma, but not for consumers ING Think

US tariffs, pricing risks to be manageable for Big Pharma, Morningstar says Reuters

Potential Accelerated Approval Path: Innate Pharma's lacutamab analyst event Oct 28, 2025 Stock Titan

Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update Business Wire

Europe’s Pharma Industry Braces for Pain as Trump Tariff Threat Looms The New York Times

Pharma companies collaborate on secure data sharing for AI Nature

Next in pharma trends 2025 PwC

Trump hints at tariff reprieve for pharma companies that bring operations back to US The Guardian

Healing the World: A Roadmap for Making India a Global Pharma Exports Hub Bain & Company

UK tumbles down global rankings for pharma investment and research Association of the British Pharmaceutical Industry (ABPI)

Building a shared vision for pharma R&D–supplier partnerships McKinsey & Company

Pharma 50: The top pharma companies in the world for 2025 drugdiscoverytrends.com

Innate Pharma Reports First Half 2025 Business Update and Financial Results Business Wire

Big Pharma Rushes to China for Deal Prospecting Despite Regulatory Uncertainty BioSpace

What can the Pharmacy First scheme do for me? Healthwatch

Innate Pharma Reports First Quarter 2025 Business Update and Financial Results Business Wire

Innate Pharma Announces €15M Investment by Sanofi Business Wire

and Announces Sanofi’s Intention to Make a Strategic Investment in the Company Business Wire

Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome Business Wire

2025 Preview: What does the year ahead hold for pharma? evaluate.com

Rewiring pharma’s regulatory submissions with AI and zero-based design McKinsey & Company

How 2025 can be a pivotal year of progress for Biopharma The World Economic Forum

Supreme Court Overrules Purdue Pharma Opioid Settlement, Rejects Immunity for Sacklers National Conference of State Legislatures

Exclusive: Pharma industry lobbies Trump for phased tariffs, sources say Reuters

For Pharma, Trump vs. Harris Is a Showdown Between Two Industry Foes KFF Health News

Innate Pharma Announces Its Participation in the 25th Edition of the European Midcap Event Yahoo Finance

Out of the shadows: A brighter future for pharma technical development McKinsey & Company

A look at the tax benefits for pharma ads Politico

What’s Next for Pharma Stocks After Trump’s Drug Price Ultimatum? Morningstar

Purdue Pharma gets over 99% voting support for bankruptcy plan Reuters

The top 10 pharma R&D budgets for 2024 Fierce Biotech

India looking beyond US for pharma exports amid tariff tensions Reuters

Fierce Pharma Asia—Approvals for Innovent, Dizal; BMS partner's bispecific ADC readout Fierce Pharma

Pharma looks for quantum leap in drug development Axios

The top 10 pharma drug ad spenders for 2023 Fierce Pharma

Purdue Pharma files new bankruptcy plan for $7.4 billion opioid settlement Reuters

Demystifying the omnichannel commercial model for pharma companies in Asia | Japan McKinsey & Company

‘Pharma package’: Council agrees its position on new rules for a fairer and more competitive EU pharmaceutical sector consilium.europa.eu

Pharma Market Forecast: Top Trends for Pharma in 2025 Investing News Network

4 principles for urgent pharma action to combat COVID-19 The World Economic Forum

A new operating model for pharma: How the pandemic has influenced priorities McKinsey & Company

The top 10 pharma drug ad spenders for 2022 Fierce Pharma

The top 10 ad spenders in Big Pharma for 2020 Fierce Pharma

How Big Pharma Reaps Profits While Hurting Everyday Americans Center for American Progress

On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M Fierce Pharma

A Prescription for the Customer-Centric Commercial Model in Pharma Bain & Company

It’s Time for Public Pharma The American Prospect

Pharma braces for tariffs as Trump threatens to buck trade convention politico.eu

“Killer Acquisitions” Study in Pharma Calls For Stricter Scrutiny Cleary Antitrust Watch

Albanese says PBS ‘not up for negotiation’ after US pharma complains to Trump about scheme The Guardian

The top 10 pharma R&D budgets for 2023 Fierce Biotech

Stars align for drugmakers in final straight of EU pharma package politico.eu

Pharma company funding for patient advocacy groups needs to be transparent The Conversation

NZ’s new disclosure scheme for pharma payments to doctors falls short of best practice The Conversation

Innate Pharma Announces Exclusive License of Antibodies to Takeda for Celiac Disease Research Program Business Wire

Ready for launch: Reshaping pharma’s strategy in the next normal McKinsey & Company

EU regulatory activity is driving comprehensive reforms for pharma in 2025 Osborne Clarke

Innate Pharma Shares Updated Results From the Sanofi Developed Blood Cancer Phase 1/2 SAR443579/IPH6101 Trial Business Wire

What’s next for pharma in emerging markets? McKinsey & Company

Africa: A continent of opportunity for pharma and patients McKinsey & Company

Pharma lobbying held deep influence over opioid policies Center for Public Integrity

For Big Pharma, the revolving door keeps spinning The Hill

What Are Barriers to Entry for Pharma Companies? Investopedia

Govt plans minimum import price for key pharma inputs Times of India

When Drug Reviewers Leave The FDA, They Often Work For Pharma KFF Health News

Expanding horizons for risk management in pharma McKinsey & Company

Pharma & Healthcare for India@100: Change Ahead EY

Health Canada and Big Pharma: Too close for comfort The Conversation

Pharma company hauled up for taking doctors on foreign trips Times of India

CAT upholds infringement decision for pay for delay pharma deals GOV.UK

£70 million in fines for pharma firms that overcharged NHS GOV.UK

Mythbusting for academics: Considering a job in biotech/pharma Science | AAAS